miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment.
暂无分享,去创建一个
H. Hermeking | David C. Corney | A. Flesken-Nikitin | A. Nikitin | J. Schimenti | R. Munroe | C. Hwang | Long-chang Jiang | Chieh-Yang Cheng | Gülfem Meryem Öner
[1] A. Bouchie. First microRNA mimic enters clinic , 2013, Nature Biotechnology.
[2] G. Enikolopov,et al. Ovarian surface epithelium at the junction area contains cancer-prone stem cell niche , 2013, Nature.
[3] Eric A Bushong,et al. Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice , 2012, Science.
[4] H. Hermeking,et al. MicroRNAs in the p53 network: micromanagement of tumour suppression , 2012, Nature Reviews Cancer.
[5] Hans Clevers,et al. Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas , 2012, Science.
[6] A. Bader. miR-34 – a microRNA replacement therapy is headed to the clinic , 2012, Front. Gene..
[7] Joana A. Vidigal,et al. Intact p53-Dependent Responses in miR-34–Deficient Mice , 2012, PLoS genetics.
[8] X. Guo,et al. miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2 , 2012, The Journal of cell biology.
[9] Yong Jin Choi,et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming , 2011, Nature Cell Biology.
[10] S. Thorgeirsson,et al. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression , 2011, Proceedings of the National Academy of Sciences.
[11] W. Gerald,et al. Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling , 2011, Nature communications.
[12] B. Verdoodt,et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas , 2011, Virchows Archiv.
[13] K. Kelnar,et al. Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44 , 2010, Nature Medicine.
[14] L. Trusolino,et al. MET signalling: principles and functions in development, organ regeneration and cancer , 2010, Nature Reviews Molecular Cell Biology.
[15] T. Deguchi,et al. MiR‐34a attenuates paclitaxel‐resistance of hormone‐refractory prostate cancer PC3 cells through direct and indirect mechanisms , 2010, The Prostate.
[16] F. Gage,et al. Puma is required for p53-induced depletion of adult stem cells , 2010, Nature Cell Biology.
[17] H. Hermeking,et al. Frequent Downregulation of miR-34 Family in Human Ovarian Cancers , 2010, Clinical Cancer Research.
[18] Y. Pilpel,et al. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC , 2010, Cell Death and Differentiation.
[19] J. Lieberman,et al. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. , 2009, Blood.
[20] Scott W. Lowe,et al. Stem cells: The promises and perils of p53 , 2009, Nature.
[21] K. Leong,et al. Generation of a prostate from a single adult stem cell , 2008, Nature.
[22] Yasunori Fujita,et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. , 2008, Biochemical and biophysical research communications.
[23] Carola Berking,et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer , 2008, Cell cycle.
[24] Wei Wang,et al. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. , 2007, Cancer research.
[25] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[26] David C. Corney,et al. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. , 2006, Cancer research.
[27] P. Dentelli,et al. p53 Mediates the Accelerated Onset of Senescence of Endothelial Progenitor Cells in Diabetes* , 2006, Journal of Biological Chemistry.
[28] K. Meletis,et al. p53 suppresses the self-renewal of adult neural stem cells , 2005, Development.
[29] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[30] T. Sun,et al. Proximal location of mouse prostate epithelial stem cells , 2002, The Journal of cell biology.